Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasia.
about
An expressed fgf4 retrogene is associated with breed-defining chondrodysplasia in domestic dogsStructural Mimicry of A-Loop Tyrosine Phosphorylation by a Pathogenic FGF Receptor 3 MutationSixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasiasHECT domain-containing E3 ubiquitin ligase Nedd4 interacts with and ubiquitinates Sprouty2.The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discoveryFibroblast growth factor signaling in myofibroblasts differs from lipofibroblasts during alveolar septation in mice.Sprouty2 regulates endochondral bone formation by modulation of RTK and BMP signalingIntermolecular interactions of Sprouty proteins and their implications in development and disease.Identification of therapeutic targets for Parkinson's disease via bioinformatics analysis.FGFR3 targeting strategies for achondroplasia.Current Care and Investigational Therapies in Achondroplasia.The physical basis of FGFR3 response to fgf1 and fgf2.Cell adaptation to activated FGFR3 includes Sprouty4 up regulation to inhibit the receptor-mediated ERKs activation from the endoplasmic reticulum.Fibroblast growth factor receptor 3 (FGFR3) is a strong heat shock protein 90 (Hsp90) client: implications for therapeutic manipulation.Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.FGFR3 biology and skeletal disease.
P2860
Q24649654-B1A99220-5145-41AA-A862-FA3DDD77CC25Q27679792-C1F0F8AB-318C-4D05-A991-930B33CA5E3AQ28252023-1EF11633-CED3-4E11-A403-DEE848F84FACQ33581236-853AB22E-107E-4C95-B310-EC00667F64FFQ35824929-ED970848-32DD-4864-938E-7F8EC1196C54Q36017774-343422E9-123D-465A-885F-5FB6CD5941A3Q36984163-E5E461E1-2765-4BA4-A272-7BFF461CE03FQ37402776-F60B7A60-937E-4792-97CC-75EFB96203FCQ37720038-7309135F-1336-4767-931A-87595D30A326Q38007566-5724D609-A286-40ED-9B75-A83A426C0B82Q38948779-D99BE5D9-3D96-48DE-850D-62F30C6986E6Q39479116-12700608-44EF-4818-88F5-33C72CF6AF64Q39798406-8746DAE0-334A-4922-B2EF-EB15F105BE5BQ42740318-EE46EF77-672C-43A1-9FD8-606F99D4061FQ52826459-AA709413-139F-4A11-AF80-B8CA24458B0FQ52936841-35EE64D0-B4CD-43B5-BA8F-835E2974553D
P2860
Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Sprouty 2 disturbs FGFR3 degra ...... form of human achondroplasia.
@en
Sprouty 2 disturbs FGFR3 degra ...... form of human achondroplasia.
@nl
type
label
Sprouty 2 disturbs FGFR3 degra ...... form of human achondroplasia.
@en
Sprouty 2 disturbs FGFR3 degra ...... form of human achondroplasia.
@nl
prefLabel
Sprouty 2 disturbs FGFR3 degra ...... form of human achondroplasia.
@en
Sprouty 2 disturbs FGFR3 degra ...... form of human achondroplasia.
@nl
P2093
P2860
P1433
P1476
Sprouty 2 disturbs FGFR3 degra ...... form of human achondroplasia.
@en
P2093
Catherine R Degnin
Changsheng Guo
Deborah Krakow
Gregory P Lunstrum
Jeanie Bihlmaier
Melanie B Laederich
Paul Holden
William A Horton
Yoon-Jae Cho
P2860
P304
P356
10.1016/J.CELLSIG.2008.04.001
P577
2008-04-10T00:00:00Z